Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bristol Myers Squibb gets USFDA priority review for expanded Reblozyl use

Ruchika Sharma1 May 2023 5:31 PM IST

Reblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.

BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report

Ruchika Sharma1 May 2023 2:15 PM IST

Bengaluru: Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay...

Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe Widens

Abbott concludes acquisition of Cardiovascular Systems

Ruchika Sharma1 May 2023 1:30 PM IST

Abbott Park, Ill: Abbott has announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an...

Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification List

59 companies get land in upcoming medical device park near Noida

Ruchika Sharma1 May 2023 12:30 PM IST

"The list of medical devices that will be manufactured at the park is quite extensive and diverse," the official said.

Bayer investors re-elect Norbert Winkeljohann as board chairman

Ruchika Sharma1 May 2023 11:23 AM IST

Frankfurt: Bayer Chairman Norbert Winkeljohann on Friday comfortably won a re-election vote at the drugmaker's annual shareholder meeting with an...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck beats first-quarter expectations on Keytruda, Gardasil strength

Ruchika Sharma30 April 2023 4:00 PM IST

Bengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...

USFDA nod to JnJ Tremfya for Crohns disease

J&J agrees to retain all talc related liabilities from litigation in US, Canada

Ruchika Sharma30 April 2023 2:30 PM IST

United States: Johnson & Johnson said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United...

Eli Lilly raises annual profit forecast on strength of diabetes drug

Ruchika Sharma30 April 2023 2:30 PM IST

Bengaluru: Eli Lilly and Co on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its...

Giovanni Caforio to retire as Bristol Myers Squibb CEO

Ruchika Sharma30 April 2023 1:30 PM IST

New York: Bristol Myers Squibb has announced that Giovanni Caforio, MD, Chairman of the Board and Chief Executive Officer, has decided to retire...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets positive CHMP opinion recommending nod for CAMZYOS for treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy

Ruchika Sharma30 April 2023 12:15 PM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca beat expectations for first-quarter profit, revenue

Ruchika Sharma30 April 2023 12:15 PM IST

London: AstraZeneca on Thursday beat expectations for its first-quarter profit and revenue, helped by sales of its roster of drugs in emerging...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa

Ruchika Sharma30 April 2023 10:00 AM IST

Cosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in the inflammation of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok